Ethyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate

Catalog No. :
ACAVSF685
CAS No. :
2989396-34-9
Molecular Formula :
C22H29N3O5
Molecular Weight :
415.49

IUPAC Name:ethyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate

Ethyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$187.00Login to see priceInquiryInquiry
10mg98%$300.00Login to see priceInquiryInquiry
25mg98%$599.00Login to see priceInquiryInquiry
50mg98%$898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate
IUPAC Nameethyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate
Molecular FormulaC22H29N3O5
Molecular Weight415.49
SMILESCCOC(=O)C1=CC2=C(C=CC(OC(C)=O)=C2)N1CC(=O)NCCN1CCCCC1
InChI KeyZTBPOVVWQRNZLJ-UHFFFAOYSA-N
SynonymEthyl 5-acetoxy-1-(2-oxo-2-((2-(piperidin-1-yl)ethyl)amino)ethyl)-1H-indole-2-carboxylate;1H-Indole-2-carboxylic acid, 5-hydroxy-1-[2-oxo-2-[[2-(1-piperidinyl)ethyl]amino]ethyl]-, ethyl ester, acetate (1:1)
CAS No.2989396-34-9

Synthetic Route by SureRoute

1. ACAVSF685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVSF685 route product structure diagram
    ACAVSF6852989396-34-9
Inquiry

2. ACAVSF685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVSF685 route product structure diagram
    ACAVSF6852989396-34-9
Inquiry

Comments (0)